Peer Review History
| Original SubmissionNovember 12, 2019 |
|---|
|
PONE-D-19-30992 Techno-Biofunctionality of Mangostins Loaded Virgin Coconut Oil Nanoemulsion and Nanoemulgel PLOS ONE Dear Dr. Panpipat, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Jan 26 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Walid Elfalleh, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 1. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed: https://www.sciencedirect.com/science/article/pii/S0023643819309612?via%3Dihub https://www.sciencedirect.com/science/article/pii/B9780123741240000247 In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript studied techno-biofunctional characteristics of mangostins loaded nanoemulsion and (nano)emulgel. The study is interesting. This manuscript is suitable for publication in PLOS one with major revision. Comments: 1. The title of the paper should be modified since the work is devoted to mangostin extracts but not to mangostins. 2. The authors should add the contents of α-mangostin and γ-mangostin in nanoemulsion and (nano)emulgel. 3. In the determination of antioxidant activities, The α- tocopherol was not only the positive control of DPPH● scavenging activity, but also the positive control of other antioxidant activities. 4. In the antioxidant activities and antibacterial activity, Blank control of nanoemulsion without mangostin extracts should be added. 5. The authors should add and explain the EC50 of positive control and blank control. 6. There are so many language errors in this manuscript. We recommend the authors asking a professional editor or native English speaker to fully improve the language of this manuscript. Reviewer #2: The manuscript mainly presents a Techno-Biofunctionality of Mangostins Loaded Virgin Coconut Oil Nanoemulsion and Nanoemulgel. I have read this paper with great interest as I can see the value of the approach investigated by the authors. However, I have a few issues in some aspects: The manuscript has a clear problem statement and solution, but it needs some revision for the English language. In fig.3 and fig.5, please indicate significant differences by different letters (statistical analysis). Could you explain more please results given in table 1. I would advise authors to complete the conclusion by adding the utility of this work. Reviewer #3: In this manuscript named “Techno-Biofunctionality of Mangostins Loaded Virgin Coconut Oil Nanoemulsion and Nanoemulgel” Chatchai Sungpud et al are presenting a detailed technical and biofunctional comparison between Mangostins loaded nanoemulsions prepared from mangosteen peel extracts recovered by 3 different extractants (VCO, PG, and mixed VCO-PG). Based on an extensive characterization, the authors established that Mangostins loaded nanoemulsions prepared from mangosteen peel extracts recovered by mixed VCO-PG nanoemulsions were globular and uniformly distributed in nanoscale with the average droplet of less than 100 nm with negatively charged Zeta potentials of particles. The authors also tested the antioxidant and antibacterial activities of the nanoemulsions. They also described the gel appearance, viscosity and mangostins release of mixed VCO-PG nanoemulgels as an excellent formulation for cosmetic based gel application. Even though the manuscript is well written, nicely detailed and organized, I have few remarks: *Abstract: Modifications should be made to showcase the importance of your work and the potential of further interesting applications. Less technical details and numbers should be included in the abstract. Changes in the structure of the sentences should be introduced to make the abstract easier to follow. *Material and Methods: Nicely detailed techniques, explanations, and equations. Since table 4 is the first table you refer to it, it should be named as table 1. *Results and discussion: In “Stability of mangostins loaded nanoemulsions” paragraph, line 367, the authors described that freeze-thaw cycles affected the pH of the nanoemulsion and confirm that the final pH is still in the acceptable range of skincare (line 369), while the original pH is out of this range (less than 4). In “Antibacterial activities” paragraph, line 447, negative controls containing the extractant should be tested side by side with the corresponding nanoemulsions. Figure 1: The illustration of the panel with the same magnification is very important but it is very hard to see the nanoemulsion of PG extract prepared using HLB 15.1 (j) at this magnification. An additional picture with higher magnification should be added to proof that the nanoemulsions are present but in a smaller size. A number of typos through the manuscript should be corrected. *Finally, this manuscript described an efficient strategy to prepare Mangostins loaded nanoemulsions prepared from mangosteen peel extracts with moderate particle size diameter scavenged more DPPH and H2O2 which can be used as a promising delivery system for bioactive polyphenol in food supplement, pharmaceutical and cosmetic. Furthermore, the VCO-PG nanoemulgel was classified as an excellent formulation for cosmetic based gel application. Reviewer #4: Overall, this is a clear, concise, and well-written manuscript. The introduction is relevant and theory based. Sufficient information about the previous study findings is presented for readers to follow the present study rationale and procedures. The methods are generally appropriate, and well described. Overall, the results are clear and convincing. Overall, this is a high quality manuscript that has implications for the theoretical basis, devet. Tables are cleae as well as figures. This work is concidered for publication. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Techno-biofunctionality of mangostin extract-loaded virgin coconut oil nanoemulsion and nanoemulgel PONE-D-19-30992R1 Dear Dr. Panpipat, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Walid Elfalleh, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): The current version of the paper seems improved an all requested corrections were incorporated on the manuscript. I consider that the paper is worthy of publication. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have addressed the reviewers' comments and improved the manuscript. Now it appears to be acceptable. Reviewer #2: (No Response) Reviewer #3: Chatchai Sungpud and al. did a very good job updating the abstract and going over the whole manuscript. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No |
| Formally Accepted |
|
PONE-D-19-30992R1 Techno-biofunctionality of mangostin extract-loaded virgin coconut oil nanoemulsion and nanoemulgel Dear Dr. Panpipat: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Walid Elfalleh Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .